Drug
Elevidys
Elevidys: highest development phase Post-Market, developed by Sarepta Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Sarepta Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| ELEVIDYS NCT07542314 | Post-Market | Duchenne Muscular Dystrophy |
Latest
No recent events.
Follow Elevidys on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.